Catalysts for NAL Pharmaceuticals Ltd
9 tracked
Mar 1, 2026
grant
SOCIETY FOR RESEARCH ON NICOTINE/TOBACCO — SRNT 2026 Annual Meeting
NAL Pharmaceuticals Ltd
→
Feb 26, 2026
approval
RIZAFILM (RIZATRIPTAN BENZOATE) — FDA approval
NAL Pharmaceuticals Ltd
→
Feb 15, 2026
grant
BOSTON UNIVERSITY MEDICAL CAMPUS — Adolescent exposure to nicotine and tobacco content on social media: incorpor...
NAL Pharmaceuticals Ltd
→
Jan 29, 2026
approval
RIZAFILM (RIZATRIPTAN BENZOATE) — FDA approval
NAL Pharmaceuticals Ltd
→
Sep 20, 2025
grant
PENNSYLVANIA STATE UNIV HERSHEY MED CTR — TLR3-cholinergic interactions underly alcohol+nicotine co-use through differe...
NAL Pharmaceuticals Ltd
→
Sep 19, 2025
grant
UNIVERSITY OF NEBRASKA LINCOLN — Nicotine-enhancement of sweetened alcohol consumption: A behavioral economic ...
NAL Pharmaceuticals Ltd
→
Sep 15, 2025
grant
RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Understanding nicotine pouch adoption and longitudinal use patterns among U.S...
NAL Pharmaceuticals Ltd
→
Dec 11, 2023
approval
RIZAFILM (RIZATRIPTAN BENZOATE) — FDA approval
NAL Pharmaceuticals Ltd
→
Apr 14, 2023
approval
RIZAFILM (RIZATRIPTAN BENZOATE) — FDA approval
NAL Pharmaceuticals Ltd
→